EXPLORING A NEW PROGNOSTIC INDEX IN 341 POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN THE “RITUXIMAB ERA”: A RETROSPECTIVE STUDY FROM SPANISH LYMPHOMA GROUP GELTAMO | Publicación